ALFA Finder| Revenue growth | 162% YoY revenue growth to ₹314cr driven by US acquisition. |
|---|---|
| Margins | EBITDA margins improving post-integration; targeting 18-20% blended range. |
| Demand visibility | Strong traction in US oilfields and recovery in apparel exports. |
| Management confidence | Extremely high, focusing on doubling US capacity and global expansion. |
Growth
Revenue grew 162% to ₹314cr; PAT rose 118% to ₹44cr. Growth is inorganic-heavy but scaling fast.
Outlook
CCT business targeted to reach $200M revenue by FY28 with 15% EBITDA margins.
Risks
Integration risk of CCT Group and geopolitical disruptions to global shipping/logistics remain primary concerns.
Earnings Call filed with BSE, NSE: FCL. Summary written with AI assistance from the document.
Fineotex Chemical Ltd: key numbers
- Share price
- ₹51.50
- Market cap
- ₹5,997 Cr
- Revenue (annual)
- ₹772.2 Cr
- Net profit (annual)
- ₹108.8 Cr
- P/E (TTM)
- 49.0×Sector 35.5×
- Promoter holding
- 62.30%+0.00% QoQ
- FII holding
- 2.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fineotex Chemical Ltd
All →Fineotex Chemical Board Meeting Date
Fineotex Chemical Ltd has scheduled a board meeting on November 13, 2026. The board will consider unaudited financial results for the quarter and half-year ended September 30, 2026.
Fineotex Chemical Merger & Restructuring Worth ₹0.05 Cr
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new US-based subsidiary, Fineotex America Inc., for ₹0.05 Crore to provide specialized water treatment solutions.
- Value
- ₹0.05 Cr
Fineotex Chemical Merger & Restructuring
Fineotex Chemical's FZE subsidiary incorporated Fineotex America Inc. in Delaware, USA. The entity will supply water treatment chemicals for data centers and semiconductors.
Fineotex Chemical Annual General Meeting
Fineotex Chemical Limited conducted its 23rd Annual General Meeting on September 11, 2026. Shareholders discussed ordinary and special business items, including dividend and fund raising proposals.
Fineotex Chemical Merger & Restructuring Worth ₹0.05 Cr
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new wholly-owned subsidiary, Fineotex Holdings Inc., in the USA for specialty chemical business activities.
- Value
- ₹0.05 Cr
Fineotex Chemical Merger & Restructuring
Fineotex Chemical Limited incorporated a new wholly-owned step-down subsidiary, Fineotex Holdings Inc., in the USA. This entity will pursue specialty chemical and growth opportunities.